Bicyclic Derivatives for Heartworm Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for heartworm infections in warm-blooded animals, particularly those using macrocyclic lactones, are often ineffective due to developing resistance and require cumbersome, time-consuming arsenic-based compounds, necessitating the need for new compounds that can effectively control or kill heartworms.

Innovation Solution

Development of compounds of formula (I′) and (I) that target heartworms, which include specific structural elements allowing for effective treatment and control of endoparasites by administering these compounds to the animals or their environment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If macrocyclic lactones are used for heartworm control, then heartworm control is achieved, but resistance develops making the treatment ineffective

Engineering Contradiction:
Improveheartworm control effectivenessVSAvoidresistance to macrocyclic lactones
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent modifies the chemical structure of macrocyclic lactones by changing molecular parameters - specifically introducing a 6- to 10-membered heteroaryl group at the C-1 position and a 4- to 7-membered heterocycloalkyl group at the C-6 position. These structural parameter changes create new compounds with different biological properties that overcome resistance while maintaining heartworm control effectiveness.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If arsenic-based compounds are used to treat adult heartworm infections, then heartworms are killed, but the treatment becomes time consuming and cumbersome

Engineering Contradiction:
Improveheartworm killing capabilityVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent develops new compounds that act as short-acting, highly effective heartworm killers. The compounds are designed to provide rapid and durable kill with reduced treatment duration compared to traditional arsenic-based compounds, making the treatment more convenient while maintaining high reliability in heartworm elimination.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If new compounds are developed to overcome resistance, then heartworm control effectiveness is improved, but the complexity of compound structure increases

Engineering Contradiction:
Improveovercoming resistanceVSAvoidcompound structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the molecular structure into distinct functional components: a core macrocyclic lactone framework combined with specific heteroaryl and heterocycloalkyl groups at defined positions. This segmentation allows systematic design and optimization of each component's contribution to resistance overcoming while managing overall structural complexity through modular assembly.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20240360116A1Bicyclic derivatives
Publication Date: 2024.10.31 ELANCO TIERGESUNDHEIT AG
  • US20240360116A1 patent drawing
  • US20240360116A1 patent drawing
  • US20240360116A1 patent drawing

AI summary

The present invention provides compounds of formula (I′):which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.